Hong Kong-listed biotechnology stocks rallied, with Wangshan Wangshui-B (02630.HK) surging over 20%, Sannoh Pharmaceuticals-B (02257.HK) rising over 16%, CStone Pharmaceuticals-B (02616.HK) climbing nearly 15%, and Ascletis Pharma-B (01672.HK) gaining over 13%.